Answer
Briumvi (ublituximab) should be avoided during pregnancy unless the potential benefit to the mother outweighs the potential risk to the foetus.
Sources for this answer
- Briumvi 150 mg concentrate for solution for infusionNeuraxpharm UK Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 2Document updated
Sources checked